Skip to main content

Table 3 Comparing patients with electrical events on Holter monitoring at baseline and after completion of treatment

From: Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

Variable Baseline After completion of treatment p value
Sinus tachycardia episodes, n = 48 35.29 ± 46 29.69 ± 27.15 0.81
Sinus bradycardia episodes, n = 40 7.88 ± 7.56 7.95 ± 8.1 0.795
PACs, n = 8 6.63 ± 7.37 7.5 ± 17.3 0.89
PVCs, n = 27 71.6 ± 147 31.89 ± 69.26 0.124
  1. Continuous variables are expressed as mean and standard deviation. PA Cs premature atrial contractions PVCs premature ventricular contractions